Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

progenipoietin-1

 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Colony-Stimulating FactorsRecombinant Proteins

Narrower (1)

SD9427

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
NKT cells have pivotal roles in immune regulation and tumor immunosurveillance. We report that the G-CSF and FMS-like tyrosine… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2003
Highly Cited
2003
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
The granulocyte colony-stimulating factor (G-CSF) and Flt-3 receptor agonist progenipoietin-1 (ProGP-1) has potent effects on… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2002
2002
Enhanced ability of the progenipoietin-1 to suppress apoptosis in human hematopoietic cells.
Repopulating hematopoietic cell compartments after myeloablative chemotherapy remains a key factor in a successful chemotherapy… Expand
2001
2001
Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
OBJECTIVE Progenipoietin-1 is an agonist of both the granulocyte colony-stimulating factor and fetal liver tyrosine kinase-3… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE